Oxymetazoline Hydrochloride; Tetracaine Hydrochloride Patent Expiration

Oxymetazoline Hydrochloride; Tetracaine Hydrochloride is Used for local anesthesia in the maxillary dental arch. It was first introduced by St Renatus Llc in its drug Kovanaze on Jun 29, 2016.


Oxymetazoline Hydrochloride; Tetracaine Hydrochloride Patents

Given below is the list of patents protecting Oxymetazoline Hydrochloride; Tetracaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Kovanaze US6413499 Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic Mar 20, 2020

(Expired)

St Renatus
Kovanaze US8580282 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration Apr 02, 2030 St Renatus
Kovanaze US9308191 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration Apr 02, 2030 St Renatus


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳